US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 1, 2013 (13 years ago)

Scopolamine 0.25 opth.

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

What was recalled

Scopolamine 0.25 opth.

Recalling firm
Natures Pharmacy & Compounding Center
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1132-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Scopolamine recalls

See all
Class II · Moderate risk Terminated

Scopolamine Hydrobromide 0.25% Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0235-2023
Class II · Moderate risk Terminated

Transderm Scop

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 10019-553-03 D-1083-2022
Class II · Moderate risk Terminated

Transderm Scop

Reason Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.

Sandoz Inc NDC 66758-208-58 D-0481-2017
Class II · Moderate risk Terminated

Transderm Scop

Reason Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

Sandoz Inc D-0133-2017